Home

PCI Biotech news

PCI Biotech Q4 2009 report
2010-02-22
PCI Biotech reports successful completion of second dose group in a Phase I/II Amphinex® trial. Strong anti-tumour response observed in all patients
2010-01-19
Subscibe to news
2009-12-09